Changes in Inflammatory and Atherogenesis Biomarkers with the 2-Drug Regimen Dolutegravir plus Lamivudine in Antiretroviral Therapy–Experienced, Virologically Suppressed People wit...

by Barber, T.J, Cahn, P.E, Donovan, C., Hernandez, B., Kisare, M., Llibre, J.M, Lo, J., Mussini, C., Sithamparanathan, M., van Welzen, B.J, van Wyk, J.
Published 2022

Week 96 Genotypic and Phenotypic Results of the Fostemsavir Phase 3 BRIGHTE Study in Heavily Treatment-Experienced Adults Living with Multidrug-Resistant HIV-1

by Ackerman, P., Cahn, P., Chabria, S., Clark, A., DeJesus, E., Diaz, R.S, Du, F., Garside, L., Gartland, M., Grossberg, R., Kozal, M., Krystal, M., Kumar, P., Lataillade, M., Mannino, F., Mendo Urbina, F., Molina, J.-M, Pierce, A., Wang, M.
Published 2022